ArticleCureus2024
Preparation of Phosphorylated Chitosan From the Cuttlebone of Sepia pharaonis and the Effect of Concentration on Oral Clinical Pathogens.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Functionalized polysaccharides for infection-resistant and regenerative therapies in gynecology.International journal of pharmaceutics: X · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChitosan, a biopolymer derived from chitin, has attracted scholarly interest because of its antibacterial, biocompatible, and biodegradable characteristics. We can phosphorylate the cuttlebone of
objectivesThe goal of this study is to look into how to make phosphorylated chitosan from cuttlebone and what effect different concentrations have on killing oral clinical pathogens like MATERIALS AND
methodsWe extracted chitin and chitosan from the cuttlebone of a specimen of
resultsPhosphorylated chitosan, in 100% concentration, had the highest inhibition zone of 14 ± 0.82 mm against
conclusionThis work successfully used the cuttlebone of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.